Stocks and InvestingStocks and Investing
Tue, January 18, 2022
Mon, January 17, 2022
Fri, January 14, 2022
Thu, January 13, 2022
Wed, January 12, 2022

Salim Syed Maintained (BIIB) at Hold with Decreased Target to $207 on, Jan 12th, 2022


Published on 2024-10-27 19:14:50 - WOPRAI, Salim Syed
  Print publication without navigation


Salim Syed of Mizuho, Maintained "Biogen Inc." (BIIB) at Hold with Decreased Target from $270 to $207 on, Jan 12th, 2022.

Salim has made no other calls on BIIB in the last 4 months.



There are 16 other peers that have a rating on BIIB. Out of the 16 peers that are also analyzing BIIB, 8 agree with Salim's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Geoff Meacham of "B of A Securities" Maintained at Hold with Decreased Target to $275 on, Thursday, December 23rd, 2021
  • Cory Kasimov of "JP Morgan" Maintained at Hold with Decreased Target to $276 on, Tuesday, December 21st, 2021
  • Brian Skorney of "Baird" Maintained at Hold with Decreased Target to $258 on, Tuesday, December 21st, 2021
  • Mohit Bansal of "Wells Fargo" Initiated at Hold and Held Target at $250 on, Thursday, December 9th, 2021
  • Salveen Richter of "Goldman Sachs" Initiated at Hold and Held Target at $271 on, Monday, December 6th, 2021
  • Brian Abrahams of "RBC Capital" Maintained at Hold with Decreased Target to $277 on, Friday, November 19th, 2021
  • Alethia Young of "Cantor Fitzgerald" Maintained at Hold with Decreased Target to $327 on, Friday, October 15th, 2021
  • Carter Gould of "Barclays" Maintained at Hold with Decreased Target to $290 on, Friday, October 8th, 2021


These are the ratings of the 8 analyists that currently disagree with Salim


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $363 on, Thursday, January 6th, 2022
  • Jay Olson of "Oppenheimer" Maintained at Buy with Decreased Target to $350 on, Wednesday, December 22nd, 2021
  • Marc Goodman of "SVB Leerink" Maintained at Buy with Decreased Target to $325 on, Monday, December 20th, 2021
  • Evan Seigerman of "BMO Capital" Initiated at Buy and Held Target at $315 on, Friday, November 19th, 2021
  • Phil Nadeau of "Cowen & Co." Maintained at Buy with Decreased Target to $375 on, Thursday, October 21st, 2021
  • Paul Matteis of "Stifel" Maintained at Strong Buy with Decreased Target to $344 on, Friday, October 15th, 2021
  • Michael Yee of "Jefferies" Maintained at Strong Buy with Decreased Target to $400 on, Friday, October 8th, 2021
  • Colin Bristow of "UBS" Maintained at Strong Buy with Decreased Target to $442 on, Thursday, September 16th, 2021